Vaccines for HPV-associated diseases
JM Skolnik, MP Morrow - Molecular Aspects of Medicine, 2023 - Elsevier
Human papillomavirus (HPV) infection represents a significant global health concern owing
to its role in the etiology of conditions ranging from benign low-grade lesions to cancers of …
to its role in the etiology of conditions ranging from benign low-grade lesions to cancers of …
HPV vaccine: uptake and understanding among global Indigenous communities–a qualitative systematic review
Background Indigenous populations have a high prevalence of Human Papillomavirus
(HPV) infection and a high incidence of HPV associated cancers, such as cervical and …
(HPV) infection and a high incidence of HPV associated cancers, such as cervical and …
Is the physiological composition of the vaginal microbiome altered in high-risk HPV infection of the uterine cervix?
T Rokos, V Holubekova, Z Kolkova, A Hornakova… - Viruses, 2022 - mdpi.com
Background: Cervical cancer is the fourth most common malignancy and fourth leading
cause of cancer death in women worldwide. More than 99.7% of cases are caused by …
cause of cancer death in women worldwide. More than 99.7% of cases are caused by …
Preventing persistence of HPV infection with natural molecules
AS Laganà, V Chiantera, S Gerli, S Proietti, E Lepore… - Pathogens, 2023 - mdpi.com
Human papillomavirus (HPV) infection is one the most common sexually transmitted
infections worldwide. In most cases, the infection is temporary and asymptomatic; however …
infections worldwide. In most cases, the infection is temporary and asymptomatic; however …
Seroprevalence of 9 human papillomavirus types in the United States, 2005–2006
G Liu, LE Markowitz, S Hariri… - The Journal of …, 2016 - academic.oup.com
Background. A 9-valent human papillomavirus (HPV) vaccine, licensed in 2014, prevents 4
HPV types targeted by the quadrivalent vaccine (6/11/16/18) and 5 additional high-risk (HR) …
HPV types targeted by the quadrivalent vaccine (6/11/16/18) and 5 additional high-risk (HR) …
Immunotherapeutic approaches for the treatment of HPV-associated (pre-) cancer of the cervix, vulva and penis
TS Rafael, J Rotman, OR Brouwer… - Journal of Clinical …, 2022 - mdpi.com
Human papillomavirus (HPV) infection drives tumorigenesis in almost all cervical cancers
and a fraction of vulvar and penile cancers. Due to increasing incidence and low vaccination …
and a fraction of vulvar and penile cancers. Due to increasing incidence and low vaccination …
Disparities in provider recommendation of human papillomavirus vaccination for US adolescents
KA Mohammed, CJ Geneus, N Osazuwa-Peters… - Journal of Adolescent …, 2016 - Elsevier
Purpose To determine the prevalence of and examine factors associated with provider
recommendation of human papillomavirus vaccination for US adolescents. Methods …
recommendation of human papillomavirus vaccination for US adolescents. Methods …
[HTML][HTML] Barriers to human papillomavirus (HPV) vaccination among young adults, aged 18–35
Abstract In the United States (US), an estimated 35,900 human papillomavirus (HPV)-related
cancers are diagnosed annually. HPV vaccines are projected to eliminate∼ 90% of these …
cancers are diagnosed annually. HPV vaccines are projected to eliminate∼ 90% of these …
[图书][B] Principles and practice of gynecologic oncology
D Chi, A Berchuck, DS Dizon, CM Yashar - 2024 - books.google.com
Completely reorganized to be more clinically focused on diagnosis and treatment, Principles
and Practice of Gynecologic Oncology, Eighth Edition, provides the up-to-date information …
and Practice of Gynecologic Oncology, Eighth Edition, provides the up-to-date information …
[HTML][HTML] Patients with LR-HPV infection have a distinct vaginal microbiota in comparison with healthy controls
Y Zhou, L Wang, F Pei, M Ji, F Zhang, Y Sun… - Frontiers in cellular …, 2019 - frontiersin.org
Condyloma acuminatum (CA) is a benign epithelium hyperplasia mainly caused by human
papillomavirus (HPV), which is now the second most common viral sexually transmitted …
papillomavirus (HPV), which is now the second most common viral sexually transmitted …